Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease

Background: Stage III nonsmall cell lung cancer (NSCLC) represents a heterogeneous group of patients. Many patients are treated with curative intent multimodality therapy, either surgical resection plus systemic therapy or chemoradiation plus immunotherapy. However, many patients are not suitable fo...

Descripción completa

Detalles Bibliográficos
Autores principales: Sathiyapalan, Arani, Baloush, Ziad, Ellis, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670056/
https://www.ncbi.nlm.nih.gov/pubmed/37999109
http://dx.doi.org/10.3390/curroncol30110689

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670056/
https://www.ncbi.nlm.nih.gov/pubmed/37999109
http://dx.doi.org/10.3390/curroncol30110689

Ejemplares similares